This document describes the technical notice related to Brexit and the clinical trials ongoing in the EU whose the Qualified Person resides in the UK
View this resource Bookmark this resource
Technical Notice to Sponsors Regarding Continuous Compliance With The EU Legislation For Clinical Trials Following The Withdrawal Of The United Kingdom From The EU
Published by European Commission, EMA) and Head of Medicines Agencies (HMA)
United KingdoBrexitWithdrawal AgreementQualified Person